Podcast: CEO Heltzen @ Executive Insights for Life Sciences Innovators
heltzenpress clippingsvideopodcast
Podcast: CEO Heltzen @ Executive Insights for Life Sciences InnovatorsApril 20, 2026
Damien Perriman interviewed for Springwise
press clippingsperrimanNCT
Springwise case study: Unpacking how eXoZymes and Cayman Chemical are rethinking chemical manufacturingApril 17, 2026
Biotech Bulls & Breakthroughs podcast: The Future of Biomanufacturing with Michael Heltzen
heltzenpress clippingsvideopodcast
Biotech Bulls & Breakthroughs podcast: The Future of Biomanufacturing with Michael HeltzenApril 13, 2026
Grow Everything podcast featuring Damien Perriman
press releasenutraceuticalsmedicinepress clippingsvideosciencepodcastperrimanNCT
eXoZymes CCO, Damien Perriman, outlines NCTx strategy and the commercial path for cell-free biomanufacturing on Grow Everything podcastApril 10, 2026
The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss Drugs
nutraceuticalspress clippingsNCT
Village Voice: The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss DrugsApril 9, 2026
Perriman at Nasdaq
investornutraceuticalsmedicinepress clippingsvideoperrimanNCT
Nasdaq: Damien Perriman interview on NCTApril 2, 2026
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026
investornutraceuticalsmedicinevideoNCTcannabinoids
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026April 1, 2026
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
press releaseinvestor
eXoZymes Provides Fourth Quarter and Full Year 2025 UpdateMarch 31, 2026
NLR: Why Use Living Cells?
biofuelmedicinepress clippingsscience
NLR: Why Use Living Cells? NLR Is Making Chemicals With Enzymes AloneMarch 26, 2026
Q4 + 2025 investor call
investor
Sign up: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026March 25, 2026
Previous page
Page 1 of 12
Next page